B
MDXG icon

Baird’s MiMedx Group MDXG Stock Holding History

Baird’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$104K Hold
10,000
– – ﹤0.01% 1279
2014
Q4 		$115K Buy
+10,000
New +$98.8K ﹤0.01% 1238

Other funds holding MDXG

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Baird's MDXG Position: Q1 2015 in Review

Baird held its MiMedx Group (MDXG) position steady in Q1 2015 at 10,000 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #1279.

Baird first reported a position in MDXG in Q4 2014 and has held it in 2 quarters since. The position peaked at $115K in Q4 2014. 147 funds tracked by Wall St. Rank hold MDXG as of Q1 2015.

  • Baird held 10,000 shares of MiMedx Group worth $104K as of Q1 2015.
  • Baird left its MiMedx Group share count unchanged in Q1 2015.
  • MiMedx Group made up ﹤0.01% of Baird's portfolio in Q1 2015, its #1279 holding.
  • Baird first reported a position in MiMedx Group in Q4 2014 and has held it in 2 quarters since.
  • Baird's MiMedx Group position peaked at $115K in Q4 2014.
  • 147 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.